The structure marked A (Chromosome 10q23.3) encodes PTEN, a lipid and protein phosphatase that normally dephosphorylates PIP3 to PIP2, thereby antagonizing the PI3K/AKT/mTOR signaling axis. Germline loss-of-function mutations in PTEN cause Cowden syndrome, the prototypical PTEN hamartoma tumor syndrome (PHTS). Loss of PTEN function permits constitutive PI3K-AKT-mTOR activation, driving cell growth, survival, and proliferation—the molecular basis for the markedly elevated lifetime risks of breast cancer (≈85%), thyroid carcinoma (≈35%), endometrial carcinoma (≈28%), and other malignancies in Cowden syndrome. This mechanism is the defining pathophysiology of PHTS spectrum disorders (Harrison 21e Ch 84; NCCN PHTS Guidelines).
Harrison 21e Ch 84; NCCN PHTS Guidelines
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.